Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1995 Mar 1;181(3):867–875. doi: 10.1084/jem.181.3.867

The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4

PMCID: PMC2191922  PMID: 7532684

Abstract

Analysis of HLA class II transgenic mice has progressed in recent years from analysis of single chain HLA class II transgenes with expression of mixed mouse/human heterodimers to double transgenic mice expressing normal human heterodimers. Previous studies have used either HLA transgenic mice in which there is a species-matched interaction with CD4 or mice which lack this interaction. Since both systems are reported to generate HLA-restricted responses, the matter of the requirement for species-matched CD4 remains unclear. We have generated triple transgenic mice expressing three human transgenes, DRA, DRB, and CD4, and compared HLA-restricted responses to peptide between human- CD4+ (Hu-CD4+) and Hu-CD4- littermates. We saw no difference between Hu- CD4+ and Hu-CD4- groups, supporting the notion that for some responses at least the requirement for species-matched CD4 may not be absolute. Evidence for positive selection of mouse T cell receptors in HLA-DR transgenic mice came both from the acquisition of new, HLA-restricted responses to various peptides and from an increased frequency of T cells using the TCR V beta 4 gene segment. An important goal with respect to the analysis of function in HLA transgenic mice is the clarification of mechanisms which underpin the recognition of self- antigens in human autoimmune disease. As a first step towards 'humanized' disease models in HLA transgenic mice, we analyzed the responses of HLA-DR transgenic mice to the human MPB 139-154 peptide which has been implicated as an epitope recognized by T cells of multiple sclerosis patients. We obtained T cell responses to this epitope in transgenic mice but not in nontransgenic controls. This study suggests that HLA transgenic mice will be valuable in the analysis of HLA-restricted T cell epitopes implicated in human disease and possibly in the design of new disease models.

Full Text

The Full Text of this article is available as a PDF (2.5 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altmann D. M., Heyes J. M., Ikeda H., Sadler A. M., Wilkinson D., Madrigal J. A., Bodmer J. G., Trowsdale J. Fine mapping of HLA class II monoclonal antibody specificities using transfected L cells. Immunogenetics. 1990;32(1):51–55. doi: 10.1007/BF01787329. [DOI] [PubMed] [Google Scholar]
  2. Altmann D. M., Sansom D., Marsh S. G. What is the basis for HLA-DQ associations with autoimmune disease? Immunol Today. 1991 Aug;12(8):267–270. doi: 10.1016/0167-5699(91)90124-C. [DOI] [PubMed] [Google Scholar]
  3. Altmann D. M., Takács K., Trowsdale J., Elliott J. I. Mouse mammary tumor virus-mediated T-cell receptor negative selection in HLA-DRA transgenic mice. Hum Immunol. 1993 Jul;37(3):149–156. doi: 10.1016/0198-8859(93)90180-9. [DOI] [PubMed] [Google Scholar]
  4. Ben-Nun A., Liblau R. S., Cohen L., Lehmann D., Tournier-Lasserve E., Rosenzweig A., Zhang J. W., Raus J. C., Bach M. A. Restricted T-cell receptor V beta gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2466–2470. doi: 10.1073/pnas.88.6.2466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Breban M., Hammer R. E., Richardson J. A., Taurog J. D. Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. J Exp Med. 1993 Nov 1;178(5):1607–1616. doi: 10.1084/jem.178.5.1607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. De Magistris M. T., Romano M., Bartoloni A., Rappuoli R., Tagliabue A. Human T cell clones define S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map. J Exp Med. 1989 May 1;169(5):1519–1532. doi: 10.1084/jem.169.5.1519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Elliott J. I., Takács K., Altmann D. M. HLA-DR and H-2E transgenes differentially mediate TCR-specific positive selection. Int Immunol. 1993 Oct;5(10):1279–1284. doi: 10.1093/intimm/5.10.1279. [DOI] [PubMed] [Google Scholar]
  8. Epstein H., Hardy R., May J. S., Johnson M. H., Holmes N. Expression and function of HLA-A2.1 in transgenic mice. Eur J Immunol. 1989 Sep;19(9):1575–1583. doi: 10.1002/eji.1830190909. [DOI] [PubMed] [Google Scholar]
  9. Fugger L., Michie S. A., Rulifson I., Lock C. B., McDevitt G. S. Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune response. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6151–6155. doi: 10.1073/pnas.91.13.6151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fukui Y., Esaki Y., Kimura A., Hirokawa K., Nishimura Y., Sasazuki T. T-cell repertoire in a strain of transgenic C57BL/6 mice with the HLA-DRA gene on the X-chromosome. Immunogenetics. 1993;37(3):204–211. doi: 10.1007/BF00191886. [DOI] [PubMed] [Google Scholar]
  11. Hammer R. E., Maika S. D., Richardson J. A., Tang J. P., Taurog J. D. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell. 1990 Nov 30;63(5):1099–1112. doi: 10.1016/0092-8674(90)90512-d. [DOI] [PubMed] [Google Scholar]
  12. Inamitsu T., Nishimura Y., Sasazuki T. Different recognition of transgenic HLA-DQw6 molecules by mouse CD4+ and CD8+ T cells. Immunogenetics. 1992;35(1):46–50. doi: 10.1007/BF00216626. [DOI] [PubMed] [Google Scholar]
  13. Kalinke U., Arnold B., Hämmerling G. J. Strong xenogeneic HLA response in transgenic mice after introducing an alpha 3 domain into HLA B27. Nature. 1990 Dec 13;348(6302):642–644. doi: 10.1038/348642a0. [DOI] [PubMed] [Google Scholar]
  14. Kievits F., Ivanyi P., Krimpenfort P., Berns A., Ploegh H. L. HLA-restricted recognition of viral antigens in HLA transgenic mice. Nature. 1987 Oct 1;329(6138):447–449. doi: 10.1038/329447a0. [DOI] [PubMed] [Google Scholar]
  15. Kievits F., Lokhorst W., Ivanyi P. Abnormal anti-viral immune response in mice is corrected in HLA-B27.2-transgenic mice. Eur J Immunol. 1990 May;20(5):1189–1192. doi: 10.1002/eji.1830200537. [DOI] [PubMed] [Google Scholar]
  16. Kotzin B. L., Karuturi S., Chou Y. K., Lafferty J., Forrester J. M., Better M., Nedwin G. E., Offner H., Vandenbark A. A. Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9161–9165. doi: 10.1073/pnas.88.20.9161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lamb J. R., Green N. Analysis of the antigen specificity of influenza haemagglutinin-immune human T lymphocyte clones: identification of an immunodominant region for T cells. Immunology. 1983 Dec;50(4):659–666. [PMC free article] [PubMed] [Google Scholar]
  18. Lampson L. A., Levy R. Two populations of Ia-like molecules on a human B cell line. J Immunol. 1980 Jul;125(1):293–299. [PubMed] [Google Scholar]
  19. Law Y. M., Yeung R. S., Mamalaki C., Kioussis D., Mak T. W., Flavell R. A. Human CD4 restores normal T cell development and function in mice deficient in murine CD4. J Exp Med. 1994 Apr 1;179(4):1233–1242. doi: 10.1084/jem.179.4.1233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lawrance S. K., Karlsson L., Price J., Quaranta V., Ron Y., Sprent J., Peterson P. A. Transgenic HLA-DR alpha faithfully reconstitutes IE-controlled immune functions and induces cross-tolerance to E alpha in E alpha 0 mutant mice. Cell. 1989 Aug 11;58(3):583–594. doi: 10.1016/0092-8674(89)90439-x. [DOI] [PubMed] [Google Scholar]
  21. Le A. X., Bernhard E. J., Holterman M. J., Strub S., Parham P., Lacy E., Engelhard V. H. Cytotoxic T cell responses in HLA-A2.1 transgenic mice. Recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element. J Immunol. 1989 Feb 15;142(4):1366–1371. [PubMed] [Google Scholar]
  22. Lorès P., Boucher V., Mackay C., Pla M., Von Boehmer H., Jami J., Barré-Sinoussi F., Weill J. C. Expression of human CD4 in transgenic mice does not confer sensitivity to human immunodeficiency virus infection. AIDS Res Hum Retroviruses. 1992 Dec;8(12):2063–2071. doi: 10.1089/aid.1992.8.2063. [DOI] [PubMed] [Google Scholar]
  23. Meunier H. F., Carson S., Bodmer W. F., Trowsdale J. An isolated beta 1 exon next to the DR alpha gene in the HLA-D region. Immunogenetics. 1986;23(3):172–180. doi: 10.1007/BF00373818. [DOI] [PubMed] [Google Scholar]
  24. Nishimura Y., Iwanaga T., Inamitsu T., Yanagawa Y., Yasunami M., Kimura A., Hirokawa K., Sasazuki T. Expression of the human MHC, HLA-DQW6 genes alters the immune response in C57BL/6 mice. J Immunol. 1990 Jul 1;145(1):353–360. [PubMed] [Google Scholar]
  25. Oksenberg J. R., Panzara M. A., Begovich A. B., Mitchell D., Erlich H. A., Murray R. S., Shimonkevitz R., Sherritt M., Rothbard J., Bernard C. C. Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature. 1993 Mar 4;362(6415):68–70. doi: 10.1038/362068a0. [DOI] [PubMed] [Google Scholar]
  26. Ota K., Matsui M., Milford E. L., Mackin G. A., Weiner H. L., Hafler D. A. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 1990 Jul 12;346(6280):183–187. doi: 10.1038/346183a0. [DOI] [PubMed] [Google Scholar]
  27. Panina-Bordignon P., Tan A., Termijtelen A., Demotz S., Corradin G., Lanzavecchia A. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur J Immunol. 1989 Dec;19(12):2237–2242. doi: 10.1002/eji.1830191209. [DOI] [PubMed] [Google Scholar]
  28. Pette M., Fujita K., Wilkinson D., Altmann D. M., Trowsdale J., Giegerich G., Hinkkanen A., Epplen J. T., Kappos L., Wekerle H. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. Proc Natl Acad Sci U S A. 1990 Oct;87(20):7968–7972. doi: 10.1073/pnas.87.20.7968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Pullen A. M., Marrack P., Kappler J. W. The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens. Nature. 1988 Oct 27;335(6193):796–801. doi: 10.1038/335796a0. [DOI] [PubMed] [Google Scholar]
  30. Salter R. D., Benjamin R. J., Wesley P. K., Buxton S. E., Garrett T. P., Clayberger C., Krensky A. M., Norment A. M., Littman D. R., Parham P. A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2. Nature. 1990 May 3;345(6270):41–46. doi: 10.1038/345041a0. [DOI] [PubMed] [Google Scholar]
  31. Schwartz B. D. HLA class II transgenic mice: the chance to unravel the basis of HLA class II associations with disease. J Exp Med. 1994 Jul 1;180(1):11–13. doi: 10.1084/jem.180.1.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Staerz U. D., Rammensee H. G., Benedetto J. D., Bevan M. J. Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor. J Immunol. 1985 Jun;134(6):3994–4000. [PubMed] [Google Scholar]
  33. Steinman L. Multiple sclerosis and its animal models: the role of the major histocompatibility complex and the T cell receptor repertoire. Springer Semin Immunopathol. 1992;14(1):79–93. doi: 10.1007/BF00197133. [DOI] [PubMed] [Google Scholar]
  34. Taketo M., Schroeder A. C., Mobraaten L. E., Gunning K. B., Hanten G., Fox R. R., Roderick T. H., Stewart C. L., Lilly F., Hansen C. T. FVB/N: an inbred mouse strain preferable for transgenic analyses. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2065–2069. doi: 10.1073/pnas.88.6.2065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Tomonari K., Lovering E., Spencer S. Correlation between the V beta 4+ CD8+ T-cell population and the H-2d haplotype. Immunogenetics. 1990;31(5-6):333–339. doi: 10.1007/BF02115007. [DOI] [PubMed] [Google Scholar]
  36. Valli A., Sette A., Kappos L., Oseroff C., Sidney J., Miescher G., Hochberger M., Albert E. D., Adorini L. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest. 1993 Feb;91(2):616–628. doi: 10.1172/JCI116242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Vignali D. A., Moreno J., Schiller D., Hämmerling G. J. Species-specific binding of CD4 to the beta 2 domain of major histocompatibility complex class II molecules. J Exp Med. 1992 Apr 1;175(4):925–932. doi: 10.1084/jem.175.4.925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Woodland D., Happ M. P., Bill J., Palmer E. Requirement for cotolerogenic gene products in the clonal deletion of I-E reactive T cells. Science. 1990 Feb 23;247(4945):964–967. doi: 10.1126/science.1968289. [DOI] [PubMed] [Google Scholar]
  39. Woods A., Chen H. Y., Trumbauer M. E., Sirotina A., Cummings R., Zaller D. M. Human major histocompatibility complex class II-restricted T cell responses in transgenic mice. J Exp Med. 1994 Jul 1;180(1):173–181. doi: 10.1084/jem.180.1.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Yamamoto K., Fukui Y., Esaki Y., Inamitsu T., Sudo T., Yamane K., Kamikawaji N., Kimura A., Sasazuki T. Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice. J Exp Med. 1994 Jul 1;180(1):165–171. doi: 10.1084/jem.180.1.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Zaller D. M., Osman G., Kanagawa O., Hood L. Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor V beta-specific antibodies. J Exp Med. 1990 Jun 1;171(6):1943–1955. doi: 10.1084/jem.171.6.1943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Zhou P., Anderson G. D., Savarirayan S., Inoko H., David C. S. Thymic deletion of V beta 11+, V beta 5+ T cells in H-2E negative, HLA-DQ beta+ single transgenic mice. J Immunol. 1991 Feb 1;146(3):854–859. [PubMed] [Google Scholar]
  43. de Kretser T. A., Crumpton M. J., Bodmer J. G., Bodmer W. F. Demonstration of two distinct light chains in HLA-DR-associated antigens by two-dimensional gel electrophoresis. Eur J Immunol. 1982 Mar;12(3):214–221. doi: 10.1002/eji.1830120309. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES